Eagle Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
Eagle Pharmaceuticals, Inc. reported Earnings Per Share, Basic and Diluted of -$0.39 per share for the 3-month period ending 2014-12-31, per its 10-K filed 2017-03-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2017-03-15
- Eagle Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2014-12-31 was -$0.39.
- Eagle Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2014-09-30 was -$0.65.
- Eagle Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2014-06-30 was -$0.21.
- Eagle Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2014-03-31 was -$0.36.
- Eagle Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2014 was -$1.97.
- Eagle Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2013 was -$3.25.
- Eagle Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2012 was -$14.11.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$0.39 10-K · filed 2017-03-15 | -$1.04 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$1.25 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$1.63 derived: net income ÷ weighted average shares · filed 2017-03-15 |
| 2014-09-30 | -$0.65 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.86 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$1.24 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$1.97 10-K · filed 2014-12-22 |
| 2014-06-30 | -$0.21 10-Q · filed 2014-08-11 | -$0.54 derived: net income ÷ weighted average shares · filed 2015-08-11 | -$1.23 10-Q · filed 2014-08-11 | -$1.54 derived: net income ÷ weighted average shares · filed 2017-03-15 |
| 2014-03-31 | -$0.36 10-Q · filed 2014-05-15 | -$1.29 10-Q · filed 2014-05-15 | -$1.65 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$1.90 derived: net income ÷ weighted average shares · filed 2017-03-15 |
| 2013-12-31 | -$1.44 10-K · filed 2017-03-15 | -$1.63 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$1.74 derived: net income ÷ weighted average shares · filed 2017-03-15 | -$3.58 derived: net income ÷ weighted average shares · filed 2017-03-15 |
| 2013-09-30 | -$0.21 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.31 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$2.14 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$3.25 10-K · filed 2014-12-22 |
| 2013-06-30 | -$0.11 10-Q · filed 2014-08-11 | -$1.95 derived: net income ÷ weighted average shares · filed 2014-08-11 | -$3.06 10-Q · filed 2014-08-11 | |
| 2013-03-31 | -$1.84 10-Q · filed 2014-05-15 | -$2.95 10-Q · filed 2014-05-15 | ||
| 2012-09-30 | -$14.11 10-K · filed 2014-12-22 |